{"name":"Vitro Biopharma Inc.","slug":"vitro-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AlloRx Stem Cells®","genericName":"AlloRx Stem Cells®","slug":"allorx-stem-cells","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AlloRx Stem Cells®","genericName":"AlloRx Stem Cells®","slug":"allorx-stem-cells","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxQM2dfYnhQVzVPUy1Bak95a1FnajhYRmpjMnpyODgzSU5wYXlFMU9sMmVVWVdjc0gtazRfYlAxbk9vQVE3eWZIVXdLTEhRZGZEemVBQnpTcFlFZ21kS3QxMnNwNnhWMDlnZFNqYXZqRXVmYU50YlYzMzVmOFFmUnNXalY4NUxKbTBQYjlUd3VVOHIxUDU1VURXN2FIbFNOeWpzOHp0b2ZBN2tFS1B3WWNOcVEtSjcwaVUwTmdOVVJSRXRYd09CbUtYdFREM3F4ajFoSy1Lb1FlY1VmYkh4eVhhczFFN2VFeHZKaU5FcXRaSS12aW5pVlVsRnlLanotX3VsQXBvSGMxQ3VCbURt?oc=5","date":"2026-03-09","type":"trial","source":"GlobeNewswire","summary":"Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026 - GlobeNewswire","headline":"Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1IWGt0aHk5LV9Ra2l3Z2FqQXB5am1RODZZaVIydHJvM2ZMX2R6bFJ4R0VGWjAwU25CdkYzY1VocnAwcGpTcnJTNXhYVU9zanB6Sk5pbE9NVk1OMURLeHM3VEdkWGRlcnPSAWxBVV95cUxOV05WRWNUVmU1Zy1QRzNXQlBwQjlUb2xieU91ekx1SmNQcXEwQ2dxVkxtaThLd21uUzFiaE1pWEVZVVJ3dUQ1RjNTelpyb3hyLVlHa3ZyT3Y5c0ZTQUM2MFRaTFNEYkp2X2E0N3c?oc=5","date":"2026-03-05","type":"pipeline","source":"BioInformant","summary":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant","headline":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUzJDQTRnQ2pOU0JoUUJRT2YxYm9Qc3hIaFY4WktwR09HeDFLaVRCQ0dRRzF4RHJ1RnN3cTFVUFUyVzVjVFJjZmpuS3VCbTlpQ1RTQi1OcnhPWFZ1ZUJWTHpDN1hwbW51UGlBdUlFU3NrYzdXSWRob1Y0Q3F1QUs3c3dNcl9sNU16amtjT2lB?oc=5","date":"2026-02-05","type":"pipeline","source":"The Motley Fool","summary":"Best Biotech Stocks of 2026 and How to Invest in Them - The Motley Fool","headline":"Best Biotech Stocks of 2026 and How to Invest in Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNYXNWNFowRVZ0bzhPbDdDN3diallMeGQzNUxlU1NKMWNYRU1kd2JrQWgtQVJ0c1RYNUM3LXZ5eGkwbXRSdGRiVmhVVGFGcUFNY21LbUNQcF9VQUZJS2ZCdkphSENWY2VsN05Dankyd2xrOHNtVjBodGVFak9CVVlGSUF6T1d1aTJmNUQxNGExbFRIZmlCVm4tazJNOXB2ZHZ2QWJJSnZsMktpak1ScUFhSmlVcTk1QmZBN0ZYaFBDSF9WWV9sZUR3YmwwZklTd25RYmc?oc=5","date":"2025-06-18","type":"pipeline","source":"McKinsey & Company","summary":"How new approach methodologies are reshaping drug discovery - McKinsey & Company","headline":"How new approach methodologies are reshaping drug discovery - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPRXI2cElqV3Z4WFBBR1ItRTgxQ1hqcTNNNGNycjc2MUwyclF5X1BSZVpHYUxJdk02aXV5OGV2T19fUnlMbU0tUjM4bDJkTHVGNjJjMm12T1lvUU1hVFZxTHdoOVRCUXAzYXFYVGI5cnAxM3BoRTNKcUtRUld2LVk1LVBKY0N1WUpLU0Vad0lZeWJRbGZwZVAtbXRNZ3BfZHBzZldxVFBWNlB1allDY1E5dWlBakxXLW9fZDRZMUlKcHRSZw?oc=5","date":"2025-01-22","type":"pipeline","source":"McKinsey & Company","summary":"Closing the women’s health gap: Biopharma’s untapped opportunity - McKinsey & Company","headline":"Closing the women’s health gap: Biopharma’s untapped opportunity - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE10RGVYYUw4ckw2VU9NTWM0ZEJHSzZhZTZkWG11UEZ5RW56VmdQamtVbXYySTIzQmVpUkhKQ3h0LXVXLU8yVGVLNnBhOEdXMV9jTlpycnNuTHpMS2dyYjNkR2QwTVgyUQ?oc=5","date":"2024-09-03","type":"pipeline","source":"Built In","summary":"20 Top Biotech Companies in India - Built In","headline":"20 Top Biotech Companies in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNTDVYOGZyaGppVFFwdXlMQmsxY3laazZMNjBmR0tXOUNXdThoaWRZVWl0M3RnUFc4aHR3TnpreXZmSi1NZ3ZPTGNTN1loZDI1eTZiTnBaR0RLcTVuVXFBLS05NXVMc1VCT01jMTB2ek84aFRpbkxCOGxtanpTTVR1bmZJdWROWmdRMV9LUkl3?oc=5","date":"2024-08-19","type":"pipeline","source":"Fortune Business Insights","summary":"Top 5 In-Vitro Diagnostics [IVD] Companies - Fortune Business Insights","headline":"Top 5 In-Vitro Diagnostics [IVD] Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPNkt6VzdROEVPT1NvQU8zY0NmVFI1cUhneTh5OERrNGRHYVdfY3ZMNnZCbk03WDNsU2psY1JZQm5kSkh6LVhDdTNfYml0cXB0WGpVZ2haSE5Ld1c5b091UTY1emNMTnVYbWRmZXFKbnF0dWdpTl9KWFR5TUg5TWZzNnByQlFOczA?oc=5","date":"2024-05-29","type":"pipeline","source":"BioPharma Dive","summary":"A biotech working on a new approach to IVF raises $33M in fresh funding - BioPharma Dive","headline":"A biotech working on a new approach to IVF raises $33M in fresh funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPM3ZWdWUzaXRfM2lhYWVueVJFcWo3NWlKak42T0Q2NGFIWmRTaVdKZ05xSWFGY2wzc2F1eE5hSUdrUERiNFYxbHp6WTN3V3pObHdteXdLRUhpalFRb2l4NnF1SDZfTWRrenlScW0yMjBoWWVuQjFNSjMwZUFoRy1kd3pjT2g2cFh1TVp3dlRPLUxQV25tN3h6U2l3WnJBNHhtNE5fR2NuZ1hpYWhlS3BndnJHRU9MVTN2eU05UFpn?oc=5","date":"2023-06-29","type":"pipeline","source":"renaissancecapital.com","summary":"VTRO IPO News - Stem cell biotech Vitro Biopharma sets terms for $10 million IPO - renaissancecapital.com","headline":"VTRO IPO News - Stem cell biotech Vitro Biopharma sets terms for $10 million IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxPN21xQkRfRU83NEtfZ1NOZl8tMmVUODA0cElnU1lWbGE3Zm1pakJSb1dfQWZBUEhDVVVXZ2hmVG9BXzdka3Y0MUJxSjVTclZWdUVYemZMWGpORDFHYU90U0NGbXY5elR5a3RLZW1LcnlSdGtFQnhmZjEtQWZaRkhpTnZCZzZoMjZkR1QxUzdadzQzYVV2Zm1wMGFHbnNiWnJCYk1kUzNVdmFBUnJNY0o0X0lWSnoxczdod21VVi14MktWYXBjQzAwb2pOQVRvSDBCdVJNQkpBU1hFV3dsY1gxNjlod0lLdmJPdkVtUlNrRG9XZm5sNW8tejJXc3N0R3VRa0JhU1V3aWoyX0xEUE93Tw?oc=5","date":"2022-10-19","type":"regulatory","source":"Business Wire","summary":"FUJIFILM Irvine Scientific PRIME-XV Stem FreezIS DMSO-Free Cryopreservation Medium to be Used in FDA-Authorized Clinical Trial - Business Wire","headline":"FUJIFILM Irvine Scientific PRIME-XV Stem FreezIS DMSO-Free Cryopreservation Medium to be Used in FDA-Authorized Clinical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOY01nbnF2bmRxYUg3REd1QVdxSU8wVVNPSG8wX2psam12SzItRHE3MEUzX3R2d2dFQXZIbHhFbnU3RFZzTHNEUXE2Xy1TWldYNG9ZMFBRZnRUc1hES016WDFnTDBHaHA4SlJTN2ZGLVhPMEk2dU1HMGRGejBSeGdtNWhwNTR0d0FoSUZjc0NJSkdVRktmd3pjU0IwaGFfT3c0eGpnVGx3VHBXNk03ZUdydHVKVk0ySUNfRjBDVlRHbERELUlkYTRCdjdxUlRlT2VNeXZmNTE2X1BZdw?oc=5","date":"2021-08-05","type":"pipeline","source":"Pharmaceutical Online","summary":"Developing A Robust In Vitro Intestinal Model For Preclinical Candidate Screening Of GI Toxicity - Pharmaceutical Online","headline":"Developing A Robust In Vitro Intestinal Model For Preclinical Candidate Screening Of GI Toxicity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBtamFJOEFQc21fNUhkc05nUGN6Rnd6UDRQVHRVUUtNaWhjYVphSkNIdUdSNEhYRk5tWk1WaTVlUzZhNXNNaWlVVUw2MXNtQWQ5VmJmQWs3Ym5ya3V6dFd6QkV3Y3FQVTDSAWxBVV95cUxPWjN3c3JQQk5PdDNJbzhuaGVYSDRINUZtbXRfQmNnYVBXcVgwVXQzM0QtaGFib2RRbk5kOWRrYnpaaF9PUDBBZDdXZ00yZm9raTBkSTFuQzl5U0xUdVNSYVNRSThyYU84Mllsc3Q?oc=5","date":"2021-04-08","type":"regulatory","source":"BioInformant","summary":"Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells® to Treat COVID-19 - BioInformant","headline":"Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells® to Treat COVID-19","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}